Company Filing History:
Years Active: 1991-1994
Title: The Innovative Contributions of Johannes Jukna
Introduction
Johannes Jukna is a notable inventor based in Gronau, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of neuronal degeneration. With a total of 3 patents to his name, Jukna's work has the potential to impact the lives of many individuals suffering from neurological disorders.
Latest Patents
Among his latest patents, Jukna has developed a compound known as Xanthines, which is described by a specific formula. This compound can also exist in the form of a pharmaceutically acceptable salt. Additionally, he has patented a method for the treatment and/or prophylaxis of disorders associated with neuronal degeneration. This method involves administering a 5-HT1.sub.A agonist to mammals, including humans, who are in need of such treatment.
Career Highlights
Throughout his career, Johannes Jukna has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Beecham Group Plc and Beecham-Wuelfing GmbH & Co. KG. His experience in these organizations has contributed to his expertise and innovative capabilities in the field.
Collaborations
Jukna has collaborated with several professionals in his field, including Charles D. Nicholson and Harald Maschler. These collaborations have likely enriched his research and development efforts, leading to his successful patent applications.
Conclusion
Johannes Jukna's contributions to the field of pharmaceuticals through his innovative patents demonstrate his commitment to advancing medical science. His work in treating neuronal degeneration holds promise for future therapeutic developments.